MENU
+Compare
PSIL
ETF ticker: NYSE ARCA
AS OF
Dec 4, 04:58 PM (EDT)
Price
$18.95
Change
+$0.62 (+3.38%)
Net Assets
18.45M

PSIL stock forecast, quote, news & analysis

The investment seeks long-term capital appreciation... Show more

PSIL
Daily Signal:
Gain/Loss:
A.I.Advisor
published price charts
These past five trading days, the ETF lost 0.00% with an average daily volume of 0 shares traded.The ETF tracked a drawdown of 0% for this period.
Interact to see
Advertisement
A.I.Advisor
a Summary for PSIL with price predictions
Dec 03, 2025

PSIL's RSI Indicator ascending out of oversold territory

The RSI Indicator for PSIL moved out of oversold territory on November 10, 2025. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 32 similar instances when the indicator left oversold territory. In of the 32 cases the stock moved higher. This puts the odds of a move higher at .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on December 03, 2025. You may want to consider a long position or call options on PSIL as a result. In of 71 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for PSIL just turned positive on November 26, 2025. Looking at past instances where PSIL's MACD turned positive, the stock continued to rise in of 34 cases over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where PSIL advanced for three days, in of 233 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In of 45 cases where PSIL's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are .

PSIL moved below its 50-day moving average on December 01, 2025 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for PSIL crossed bearishly below the 50-day moving average on November 11, 2025. This indicates that the trend has shifted lower and could be considered a sell signal. In of 9 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where PSIL declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

PSIL broke above its upper Bollinger Band on November 28, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

The Aroon Indicator for PSIL entered a downward trend on December 03, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

A.I.Advisor
published Highlights

Notable companies

The most notable companies in this group are Intra-Cellular Therapies (NASDAQ:ITCI).

Industry description

The investment seeks long-term capital appreciation. The fund is an actively managed ETF that seeks to achieve its investment objective by investing, under normal circumstances, at least 80% of its net assets (plus any borrowings for investment purposes) in securities of companies that derive at least 50% of their net revenue from or devote 50% of their assets to psychedelic drugs and derivatives that have economic characteristics similar to such securities. The fund primarily invests in publicly listed life sciences companies focused on psychedelic medicines as well as other companies with activities in the psychedelics business. The fund is non-diversified.

Market Cap

The average market capitalization across the AdvisorShares Psychedelics ETF ETF is 1.29B. The market cap for tickers in the group ranges from 3.33M to 15.15B. NBIX holds the highest valuation in this group at 15.15B. The lowest valued company is PBM at 3.33M.

High and low price notable news

The average weekly price growth across all stocks in the AdvisorShares Psychedelics ETF ETF was 34%. For the same ETF, the average monthly price growth was 53%, and the average quarterly price growth was 379%. IXHL experienced the highest price growth at 25%, while CMND experienced the biggest fall at -28%.

Volume

The average weekly volume growth across all stocks in the AdvisorShares Psychedelics ETF ETF was 29%. For the same stocks of the ETF, the average monthly volume growth was 458% and the average quarterly volume growth was 801%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 45
P/E Growth Rating: 77
Price Growth Rating: 60
SMR Rating: 90
Profit Risk Rating: 93
Seasonality Score: 25 (-100 ... +100)
View a ticker or compare two or three
PSIL
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published General Information

General Information

Category MiscellaneousSector

Profile
Fundamentals
Details
Category
Miscellaneous Sector
Address
AdvisorShares Trust Suite 7003 Bethesda Metro CenterBethesda
Phone
(202) 684-6383
Web
www.advisorshares.com